UTHR 8-K 2026-10-14

UNITED THERAPEUTICS Corp (UTHR) 8-K dated 2026-10-14 — accession 0001104659-26-115723. This URL is the filing, not the UTHR hub.

UNITED THERAPEUTICS Corp (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.

UNITED THERAPEUTICS Corp filed a 8-K on 2026-10-14. Accession 0001104659-26-115723.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported UTHR revenue for 2025-12-31 was $3.18B. Net income was $1.33B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 19.5.

Not investment advice. The UTHR SEC hub lists recent forms. The stock page is the research view.